ESTIMATING THE COST EFFECTIVENESS OF VILDAGLIPTIN VERSUS SULPHONYLUREA IN COMBINATION WITH METFORMIN- CLINICAL GUIDELINES VERSUS CLINICAL PRACTICE
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1293
https://www.valueinhealthjournal.com/article/S1098-3015(16)01361-9/fulltext
Title :
ESTIMATING THE COST EFFECTIVENESS OF VILDAGLIPTIN VERSUS SULPHONYLUREA IN COMBINATION WITH METFORMIN- CLINICAL GUIDELINES VERSUS CLINICAL PRACTICE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01361-9&doi=10.1016/j.jval.2016.03.1293
First page :
A202
Section Title :
Diabetes/Endocrine Disorders - Cost Studies
Open access? :
No
Section Order :
637